Koyfin Home > Directory > Health Care > Amphastar Pharma > Return on Equity %

Amphastar Pharma Return on Equity % Chart (AMPH)

Amphastar Pharma annual/quarterly Return on Equity % from 2014 to 2018.
  • Amphastar Pharma Return on Equity % for the quarter ending December 12, 2018 was 1.95 a 547.96% increase of 10.67 year over year
  • Amphastar Pharma Return on Equity % for the last 12 months ending December 12, 2018 was -1.90 a 41.39% decrease of -0.79 year over year
  • Amphastar Pharma Annual Return on Equity % for 2018 was -1.90 a 171.97% decrease of -3.26 from 2017
  • Amphastar Pharma Annual Return on Equity % for 2017 was 1.37 a -146.78% decrease of -2.01 from 2016
  • Amphastar Pharma Annual Return on Equity % for 2016 was 3.37 a 128.63% increase of 4.34 from 2015
Other Margins & Efficiency Metrics:
  • Amphastar Pharma EBITDA Margin for the quarter ending December 12, 2018 was $6m a 248.20% increase of 16m year over year
  • Amphastar Pharma Return on Capital % for the quarter ending December 12, 2018 was 0.96 a 742.79% increase of 7.11 year over year
View Chart On Koyfin

Quarterly AMPH Return on Equity % Data

12/20181.95
09/20181.95
06/2018-3.45
03/2018-8.72
12/20171.76
09/20170.12
06/20172.39
03/20171.09
12/2016-3.34
09/20164.89

Annual AMPH Return on Equity % Data

2018-1.90
20171.37
20163.37
2015-0.97
2014-4.01
20134.89